Megestrol acetate

Megestrol acetate is a lipid of Sterol Lipids (ST) class. Megestrol acetate is associated with abnormalities such as Anorexia, Malnutrition, HIV Infections, Thrombocytopenia and Exanthema. The involved functions are known as Bleeding of vagina, Agent, Cell Survival, Cytopenia and Regulation. The associated genes with Megestrol acetate are Genome. The related lipids are Steroids. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Megestrol acetate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Megestrol acetate?

Megestrol acetate is suspected in Anorexia, Secondary hypocortisolism, Wasting, Malnutrition, HIV Infections, Thrombocytopenia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Megestrol acetate

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Small Cell D018288 21 associated lipids
Cachexia D002100 21 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Megestrol acetate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Megestrol acetate?

There are no associated biomedical information in the current reference collection.

What functions are associated with Megestrol acetate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Megestrol acetate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Megestrol acetate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Megestrol acetate?

Xenograft Model

Xenograft Model are used in the study 'The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo.' (Zhang K and Chow PK, 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Megestrol acetate

Download all related citations
Per page 10 20 50 100 | Total 1026
Authors Title Published Journal PubMed Link
Falcone F et al. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. 2017 J Gynecol Oncol pmid:27670256
Gungor T et al. Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey. 2016 Taiwan J Obstet Gynecol pmid:27343306
Nanjappa S et al. Pharmacy Report: Megestrol Acetate-Induced Adrenal Insufficiency. 2016 Cancer Control pmid:27218795
Myers AP et al. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study. 2016 Gynecol. Oncol. pmid:27016228
Lachowicz M et al. New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate. 2016 Molecules pmid:26861275
Han HS et al. A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study. 2015 Oncologist pmid:26463869
Ha ES et al. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process. 2015 Drug Des Devel Ther pmid:26345723
Zaza KJ et al. Vulvar extrauterine endometrial stromal sarcoma: A case report and literature review. 2015 Hematol Oncol Stem Cell Ther pmid:25585306
Fan F et al. Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs. 2015 Toxicol. Sci. pmid:25752796
Bozzetti F Management of cancer cachexia. 2014 Jan-Feb Tumori pmid:24675503
Kanat O Management of cancer cachexia (reply). 2014 Jan-Feb Tumori pmid:24675504
Ordu C et al. Can megestrol acetate induce thrombosis in advanced oncology patients receiving chemotherapy? 2014 Asian Pac. J. Cancer Prev. pmid:25556442
Tabrizi AD et al. Antiproliferative effect of metformin on the endometrium--a clinical trial. 2014 Asian Pac. J. Cancer Prev. pmid:25556427
Mittal N et al. Fenretinide: a novel treatment for endometrial cancer. 2014 PLoS ONE pmid:25340777
Kiagia M et al. Quality of life in patients with pancreatic cancer. 2014 JOP pmid:25076331
Shan W et al. Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia. 2014 J Gynecol Oncol pmid:25045434
Kim MK and Seong SJ Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method? 2014 J Gynecol Oncol pmid:25045426
Jang K et al. Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state. 2014 Drug Des Devel Ther pmid:25028536
Fernández-Lucas M et al. Anorexia and megestrol acetate: treatment versus placebo controlled study. 2014 Nefrologia pmid:24849061
Cuvelier GD et al. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy. 2014 Pediatr Blood Cancer pmid:24167059
Fleming GF et al. Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study. 2014 Gynecol. Oncol. pmid:24456823
Greig CA et al. Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy. 2014 Support Care Cancer pmid:24389826
Han J et al. The synthetic progestin megestrol acetate adversely affects zebrafish reproduction. 2014 Aquat. Toxicol. pmid:24647012
Simpson AN et al. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. 2014 Gynecol. Oncol. pmid:24561246
Kanat O et al. Comparison of three different treatment modalities in the management of cancer cachexia. 2013 Mar-Apr Tumori pmid:23748819
Kwan L et al. Adrenal insufficiency in a peritoneal dialysis patient taking megestrol acetate. 2013 Jan-Feb Perit Dial Int pmid:23349204
Morgan RE et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. 2013 Toxicol. Sci. pmid:23956101
Seo JH et al. Rapid and sensitive LC-MS/MS method for determination of megestrol acetate in human plasma: application to a human pharmacokinetic study. 2013 Biomed. Chromatogr. pmid:22961730
Yeh YT et al. Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects. 2013 Biomed Res Int pmid:23484104
Delitala AP et al. Primary symptomatic adrenal insufficiency induced by megestrol acetate. 2013 Neth J Med pmid:23412818
Greenberg M et al. Low-dose megestrol acetate revisited: a viable adjunct to surgical sterilization in free roaming cats? 2013 Vet. J. pmid:23499239
Shan BE et al. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women. 2013 Arch. Gynecol. Obstet. pmid:23644919
Park JY et al. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. 2013 Gynecol. Oncol. pmid:23283299
Park JY et al. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. 2013 Obstet Gynecol pmid:23262938
Argilés JM et al. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate. 2013 Clin Nutr pmid:23395103
Ruiz-González I et al. Different influence of ovine estrus synchronization treatments on caruncular early angiogenesis. 2013 Histol. Histopathol. pmid:23348391
Dobrila-Dintinjana R et al. Nutritional support in patients with colorectal cancer during chemotherapy: does it work? 2013 Hepatogastroenterology pmid:23108082
Park JY et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). 2013 Eur. J. Cancer pmid:23072814
Ruiz Garcia V et al. Megestrol acetate for treatment of anorexia-cachexia syndrome. 2013 Cochrane Database Syst Rev pmid:23543530
Voorhorst MJ et al. Successful treatment for subinvolution of placental sites in the bitch with low oral doses of progestagen. 2013 Reprod. Domest. Anim. pmid:23565694
Park JY et al. Hormonal therapy for women with stage IA endometrial cancer of all grades. 2013 Obstet Gynecol pmid:23743459
Fox P et al. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. 2013 Br. J. Cancer pmid:23778526
Xiangying M et al. Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer. 2013 Swiss Med Wkly pmid:23740185
Fernández-Lucas M et al. Treatment with megestrol acetate increases muscle mass in uraemic patients. 2013 Nefrologia pmid:23712229
Cao DY et al. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin]. 2013 Zhonghua Fu Chan Ke Za Zhi pmid:24284224
Chen CT et al. Muscle wasting in hemodialysis patients: new therapeutic strategies for resolving an old problem. 2013 ScientificWorldJournal pmid:24382946
Akman L et al. Reproductive outcomes after progestin therapy in infertile women with endometrial atypical hyperplasia. 2013 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:24459705
Qian JF et al. [Clinical efficacy and safety of megestrol acetate vaginal ring]. 2013 Zhonghua Yi Xue Za Zhi pmid:24300272
Qiu C et al. Sterol regulatory element-binding protein-1/fatty acid synthase involvement in proliferation inhibition and apoptosis promotion induced by progesterone in endometrial cancer. 2013 Int. J. Gynecol. Cancer pmid:24105476
Hong S et al. Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer. 2013 J. Korean Med. Sci. pmid:23678259
Coloma PM et al. Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. 2013 PLoS ONE pmid:24015213
Yaxley A et al. Pharmacological interventions for geriatric cachexia: a narrative review of the literature. 2012 J Nutr Health Aging pmid:22323350
Cincioglu M et al. Indinavir inhibits the expression of cytoplasmic aromatase and nuclear SREBP in the hippocampus of reperfusion injury-induced ischemic rats. 2012 J. Steroid Biochem. Mol. Biol. pmid:22342839
de Graeff A et al. [Malnutrition in patients with cancer]. 2012 Ned Tijdschr Geneeskd pmid:22992244
Macciò A et al. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. 2012 Gynecol. Oncol. pmid:22198049
Madeddu C et al. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. 2012 Clin Nutr pmid:22047681
Delaney AA et al. Successful pregnancy after fertility-sparing local resection and uterine reconstruction for low-grade endometrial stromal sarcoma. 2012 Obstet Gynecol pmid:22825274
Jin Y et al. [Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone]. 2012 Zhonghua Fu Chan Ke Za Zhi pmid:22883527
Wen HS et al. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide. 2012 Chemotherapy pmid:23406994
Asa C et al. AZA Wildlife Contraception Center programme for wild felids and canids. 2012 Reprod. Domest. Anim. pmid:23279543
Xiao-Yu P et al. Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa. 2012 Int. J. Gynecol. Cancer pmid:23095775
Mentrikoski MJ et al. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy. 2012 Am. J. Clin. Pathol. pmid:23010707
Kaore SN et al. Novel actions of progesterone: what we know today and what will be the scenario in the future? 2012 J. Pharm. Pharmacol. pmid:22775208
Abstracts of the 6th cachexia conference, milan, Italy, december 8-10, 2011 (part 2). 2012 J Cachexia Sarcopenia Muscle pmid:22460563
Misra Y et al. Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis. 2012 Physiol. Genomics pmid:22085904
Park H et al. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium. 2012 Arch. Gynecol. Obstet. pmid:21706284
Carvalho FM et al. Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases. 2012 Clin Med Insights Case Rep pmid:22661902
Lyng MB et al. Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. 2012 PLoS ONE pmid:22623953
Chen L et al. 6β-Methyl-3,20-dioxopregn-4-en-17-yl acetate. 2012 Acta Crystallogr Sect E Struct Rep Online pmid:22590046
Domański M and Ciechanowski K Sarcopenia: a major challenge in elderly patients with end-stage renal disease. 2012 J Aging Res pmid:22536505
Mehasseb MK and Latimer JA Controversies in the management of endometrial carcinoma: an update. 2012 Obstet Gynecol Int pmid:22518164
Santos S et al. Sequence variants and haplotype analysis of cat ERBB2 gene: a survey on spontaneous cat mammary neoplastic and non-neoplastic lesions. 2012 Int J Mol Sci pmid:22489125
Beck MM et al. Benign metastasising leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. 2012 Hong Kong Med J pmid:22477740
Toydemir TS et al. Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats. 2012 Theriogenology pmid:22015158
Li J and Winkler M Decompensated septic shock in the setting of megace-induced severe adrenal suppression in an otherwise healthy pediatric patient: a case report. 2012 Pediatr Emerg Care pmid:22863821
Shirali E et al. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate. 2012 Arch. Gynecol. Obstet. pmid:21805142
Gołębiewska JE et al. Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients. 2012 Int Urol Nephrol pmid:21805328
Han HS et al. A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients. 2012 Support Care Cancer pmid:21850416
Gullett NP et al. Nutritional interventions for cancer-induced cachexia. 2011 Mar-Apr Curr Probl Cancer pmid:21420558
Rogers ES et al. A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study. 2011 BMC Cancer pmid:22111896
Herrejón A et al. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss]. 2011 Med Clin (Barc) pmid:21524765
Zang J et al. Antiemetic activity of megestrol acetate in patients receiving chemotherapy. 2011 Support Care Cancer pmid:20419494
Agrawal A et al. Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer. 2011 World J Surg Oncol pmid:21906312
Donohoe CL et al. Cancer cachexia: mechanisms and clinical implications. 2011 Gastroenterol Res Pract pmid:21760776
Kittaneh M and Glück S Exemestane in the adjuvant treatment of breast cancer in postmenopausal women. 2011 Breast Cancer (Auckl) pmid:22084574
Cruz Jurado J et al. Management of patients with metastatic breast cancer. 2011 Adv Ther pmid:21922395
Karimi Zarchi M et al. Fertility sparing treatments in young patients with gynecological cancers: Iranian experience and literature review. 2011 Asian Pac. J. Cancer Prev. pmid:22292620
Yaxley A and Miller MD The challenge of appropriate identification and treatment of starvation, sarcopenia, and cachexia: a survey of Australian dietitians. 2011 J Nutr Metab pmid:22235370
Cho SJ et al. Uterine adenocarcinoma with feline leukemia virus infection. 2011 Lab Anim Res pmid:22232645
Davar D et al. Adjuvant therapy: melanoma. 2011 J Skin Cancer pmid:22220281
Liu B et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. 2011 J Transl Med pmid:21762495
Huang MI et al. Endometrial stromal sarcoma metastasis to the lumbar spine and sphenoid bone. 2011 Rare Tumors pmid:22066034
Jeong SJ Nutritional approach to failure to thrive. 2011 Korean J Pediatr pmid:22025919
Ayers B et al. A randomised controlled trial of cognitive-behavioural therapy for women with problematic menopausal hot flushes: MENOS 2 trial protocol. 2011 BMJ Open pmid:22021738
Thakkar HP et al. Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement. 2011 J Pharm Bioallied Sci pmid:21966165
Bibas M et al. HIV-Associated Venous Thromboembolism. 2011 Mediterr J Hematol Infect Dis pmid:21869916
Muckaden M et al. Paediatric palliative care: theory to practice. 2011 Indian J Palliat Care pmid:21811373
Kim JS et al. Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results. 2011 Korean J Hepatol pmid:21757983
Quinn LS and Anderson BG Interleukin-15, IL-15 Receptor-Alpha, and Obesity: Concordance of Laboratory Animal and Human Genetic Studies. 2011 J Obes pmid:21603270
Sinha U et al. Human immunodeficiency virus endocrinopathy. 2011 Indian J Endocrinol Metab pmid:22028995